Cyberattacks are vastly more sophisticated and pharma industry is a major target
Pharma and biopharma companies need to reevaluate the measures they are currently taking against ever-evolving cybercrime tactics, says an expert.
Pharma and biopharma companies need to reevaluate the measures they are currently taking against ever-evolving cybercrime tactics, says an expert.
Touchlight, a synthetic DNA producer, says it has received the first phase of planning approval for breaking ground on its new research and manufacturing facility in Hampton, UK.
The new alliance will focus on the development and manufacturing of complex medicines including biologics, vaccines, nucleic acids and cell and gene therapies; as well as looking to launch companies to advance the manufacture of such medicines.
AION Labs, a ‘first-of-its-kind’ innovation lab that will create and adopt AI technology to transform the process of drug discovery and development, has officially launched this month.